TCA
HOLX

Transcend Capital Advisors’s Hologic HOLX Stock Holding History

Transcend Capital Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,768
Closed -$213K – 517
2022
Q1 		$213K Buy
+2,768
New +$199K 0.02% 468

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Transcend Capital Advisors's HOLX Position: Q2 2022 in Review

Transcend Capital Advisors sold out of Hologic (HOLX) in Q2 2022, closing a stake of 2,768 shares — an estimated $213K sold.

Transcend Capital Advisors first reported a position in HOLX in Q1 2022 and held it in 1 quarter. The position peaked at $213K in Q1 2022. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Transcend Capital Advisors reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Transcend Capital Advisors sold 2,768 Hologic shares in Q2 2022, an estimated $213K.
  • Transcend Capital Advisors first reported a position in Hologic in Q1 2022 and held it in 1 quarter.
  • Transcend Capital Advisors's Hologic position peaked at $213K in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Transcend Capital Advisors's 13F filing for Q2 2022, filed 12 Jul 2022.